Sanofi-Aventis to expand diabetes and thrombosis work with Euro RSCG
November 17, 2006Medical Communications
Sanofi-Aventis has retained the agency Euro RSCG Life to promote two of its major brands around the world, insulin analogue …
NICE to face judicial review over Alzheimer’s drug decision
November 17, 2006Legal action is to be taken against NICE over its decision to withdraw approval for NHS drugs for mild and …
Surprise delay for Novartis’ Galvus
November 15, 2006Sales and Marketing Galvus, diabetes
The FDA will take three months longer than expected to review Novartis' new diabetes treatment, Galvus, after the pharma company …
Trained to win
November 13, 2006Business Services, Sales and Marketing marketing, sales, training
Pharmaceutical sales and marketing managers have a dizzying array of training courses, educational aids and events at their disposal, all …
Genentech to buy biotech Tanox for $900 million
November 10, 2006Sales and Marketing Genentech
Genentech is to pay $919 million for Tanox, a biotech company which specialises in monoclonal antibodies.Genentech has been working with …
iPod-ready patient information leaflets coming soon
November 10, 2006Sales and Marketing patients
From next month, patients will be able to learn about their medicines by listening to an iPod, MP3 player or …
Roche sponsor early breast cancer leaflet
November 10, 2006Medical Communications
Roche is backing a new leaflet designed to help patients with newly diagnosed early breast cancer make sense of the …
US Democrats to target pharmaceutical prices
November 10, 2006Sales and Marketing
The decisive victory of the Democrat party in the US mid-term elections looks set to bring new pressure on pharmaceutical …
UK biotech comes to market
November 10, 2006Research and Development biotech, investment
At last, the signals are getting stronger that the biotechnology industry is poised and ready to tackle the publicly quoted …
Sepsis drug put back at least two years
November 9, 2006Research and Development
AstraZeneca is being forced to conduct a second phase II trial on its sepsis drug, CytoFab.This follows discussions with US, …
‘Pulsed’ vitamin D drug could transform advanced prostate cancer treatment
November 9, 2006Research and Development
American biotech company Novacea says it could be on the brink of revolutionising the prostate cancer market if phase III …
Abbott buys cholesterol drug specialists Kos
November 9, 2006Sales and Marketing
Abbott is to pay $3.7 billion for Kos, the specialist US pharma company which has developed a number of major …
Novartis to be first pharma to conduct R&D in China
November 7, 2006Research and Development Asia, China, Novartis, em
Novartis is to open a major, new pharmaceutical research and development centre in China, becoming the first company in the …
Once-a-day colitis drug could take on the leaders
November 7, 2006Sales and Marketing
Shire is hoping its new, one-a-day treatment approach for ulcerative colitis (UC) will give the market leaders a run for …
First class relationships
November 6, 2006Medical Communications, Sales and Marketing industry relations, key opinion leaders, pharma
Pharma goes 'no frillls'Provocative headlines drawing attention to inappropriate behaviour and misconduct in the medical and pharmaceutical professions have been …
New drive to cut millions from branded sales on NHS
November 3, 2006Sales and Marketing generics
Some of the UK's top selling medicines are to be targeted in a new NHS drive to cut millions from …
New clinical trials agreement to improve UK research
November 3, 2006Research and Development
The Department of Health has revised its routine contract for industry-funded NHS clinical trials as a way of improving their …
Teva and Schering-Plough UK to collaborate on bowel drug
November 3, 2006Sales and Marketing
Teva has signed a deal with Schering-Plough UK to co-promote its ulcerative colitis and Crohn's disease treatment, Mesren.Teva hopes that …
UK industry launches ‘manifesto’ to speed uptake of new medicines
November 2, 2006Sales and Marketing
Pharmaceutical industry organisation, the ABPI, has launched a new campaign to increase the uptake of new medicines in the UK, …
NHS staff unite in protest against government policies
November 1, 2006NHS employees from across England gathered in Westminster to protest against government reforms and cuts to the health service, which …
Latest content
